News

Investors are worried Novo Nordisk's competition with Eli Lilly is heating up and that the first-to-market GLP-1 leader is ...
Investors are worried Novo Nordisk's competition with Eli Lilly is heating up and that the first-to-market GLP-1 leader is losing ground.
Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, cut its ...
You can take Wegovy (semaglutide) in carry-on luggage when flying, but you’ll need to declare it at security for screening. It’s also important to keep Wegovy within certain temperature ranges ...
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...
To be clear, the word "orforglipron" won't appear on Eli Lilly's consumer-facing packaging if it ever hits the market. It's the drug's generic ... such as Novo Nordisk's Wegovy and Ozempic.
Though they have taken the world by storm, GLP-1 drugs like semaglutide — sold as Ozempic and Wegovy — remain costly, require refrigeration, and need to be injected, imposing significant obstacles to ...
The FDA alert follows confirmation from Novo Nordisk, the manufacturer of Ozempic and the weight loss drug Wegovy ... on alert for additional suspicious packaging, specifically "lots labeled ...
It should cost much less to make than peptides and does not require packaging in special ... Nordisk now offer their injectable drugs, Zepbound and Wegovy, for $500 a month in most cases for ...